All manufacturing activities at Indian pharma company Marion Biotech Pvt Ltd have been halted following allegations from Uzbekistan that at least 18 children in the country died after ingesting the drug after drinking the company's syrup.
New Delhi: All manufacturing activities at Indian pharma company Marion Biotech Pvt Ltd have been halted following allegations from Uzbekistan that at least 18 children in the country died after ingesting the drug after drinking the company’s syrup. The manufacturing activities have been put on hold following an inspection by the Central Drugs Standard Control Organization (CDSCO).
In a tweet, Union Health Minister Mansukh Mandaviya said, “All manufacturing activities of Marion Biotech at Noida unit stopped last night after inspection.” Further investigation by government agencies is on. Samples of cough syrup have been taken from the manufacturing premises and sent to Regional Drug Testing Laboratory (RDTL), Chandigarh for testing.
Following inspection by @CDSCO_INDIA_INF team in view of reports of contamination in cough syrup Dok1 Max, all manufacturing activities of Marion Biotech at NOIDA unit have been stopped yesterday night, while further investigation is ongoing.
— Dr Mansukh Mandaviya (@mansukhmandviya) December 30, 2022
A joint inspection of the Noida based company of the manufacturer was carried out by the teams of Uttar Pradesh Drug Control Department and CDSCO.
The Foreign Ministry said on Thursday that Uzbekistan has initiated legal action in connection with the cough syrup death. Uzbekistan has claimed that a cough syrup made by Noida-based Marion Biotech killed 18 children.
“We are providing consular assistance to some people associated with an Indian firm there,” the Ministry of External Affairs said in an official statement. The reason has sought details of the investigation in Uzbekistan.